Related references
Note: Only part of the references are listed.Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-Preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: a Rabbit Ocular Surface Study
Hong Liang et al.
ADVANCES IN THERAPY (2011)
Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
Evaluation of Acute Corneal Barrier Change Induced by Topically Applied Preservatives Using Corneal Transepithelial Electric Resistance In Vivo
Mao Kusano et al.
CORNEA (2010)
Preoperative Nonsteroidal Anti-inflammatory Drug or Steroid and Outcomes after Trabeculectomy A Randomized Controlled Trial
Christophe Breusegem et al.
OPHTHALMOLOGY (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
F. Honrubia et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension
Gianluca Manni et al.
JOURNAL OF GLAUCOMA (2009)
Evaluation of Biomarkers of Inflammation in Response to Benzalkonium Chloride on Corneal and Conjunctival Epithelial Cells
Seth P. Epstein et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Malik Y. Kahook et al.
CORNEA (2008)
Duration of IOP reduction with travoprost BAK-free solution
Ronald L. Gross et al.
JOURNAL OF GLAUCOMA (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Side Effects Associated with Prostaglandin Analog Therapy
Albert Alm et al.
SURVEY OF OPHTHALMOLOGY (2008)
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
F. Topouzis et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
Acute corneal epithelial change after instillation of benzalkonium chloride evaluated using a newly developed in vivo corneal transepithelial electric resistance measurement method
Masafumi Uematsu et al.
OPHTHALMIC RESEARCH (2007)
The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Richard W. Yee
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Travoprost 0.004% with and without benzalkonium chloride: A comparison of safety and efficacy
Richard A. Lewis et al.
JOURNAL OF GLAUCOMA (2007)
Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%
J. Garcia-Feijoo et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Sustained effect of travoprost on diurnal and nocturnal intraocular pressure
Arthur J. Sit et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated Intraocular pressure
HB Dubiner et al.
CLINICAL THERAPEUTICS (2004)
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study
PJ Pisella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy
K Inoue et al.
JOURNAL OF GLAUCOMA (2003)
Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride
T Ishibashi et al.
JOURNAL OF GLAUCOMA (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure - A 6-month, masked, multicenter trial
RL Fellman et al.
OPHTHALMOLOGY (2002)
Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%
S Orengo-Nania et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
PA Netland et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Washout periods for brimonidine 0.2% and latanoprost 0.005%
WC Stewart et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Share Paper
